| |
Control |
Glucevia® |
| Initial Fasting Blood Glucose (mg/dl) |
202.17 ± 28.39 |
202.00 ±56.20 |
| Final Fasting Blood Glucose (mg/dl) |
791.25 ± 140.44 |
726.31 ± 127.63 |
| Insulin (mU/L) |
5.60 ± 0.82 |
4.39 ± 1.50* |
| HOMA-IR |
9.55 ± 1.33 |
5.36 ± 2.53* |
| Total cholesterol (mg/dl) |
143.63 ± 24.77 |
133.12 ± 36.43 |
| HDL-C (mg/dl) |
88.00 ± 21.07 |
88.81 ± 35.05 |
| Triglycerides (mg/dl) |
264.83 ± 49.35 |
162.72 ± 73.90* |
| Adiponectin (µg/ml) |
10.67 ± 1.79 |
13.14 ± 0.06 |
|
| Table 2: The effect of Glucevia® on plasmatic markers in BKS db/db mice. |
|
